Rapise v8.3: AI-Powered Test Automation Redefining Quality Assurance
WASHINGTON, Jan. 14, 2025 /PRNewswire/ -- Inflectra unveils Rapise v8.3 - Inflectra's Codeless Test Automation platform, a groundbreaking release that integrates Generative AI into test automation, enabling businesses to deliver high-quality software faster, and with lower risk. Built on AWS Bedrock, and designed to address the complexities of modern software delivery, Rapise v8.3 transforms how teams approach quality assurance by reducing manual effort, accelerating testing cycles, and improving scalability.
In a technological era when single point of failure is not an option, and speed and precision are critical, Rapise v8.3 sets a new benchmark for AI-driven innovation in software testing.
The Business Impact of AI in Rapise
Rapise v8.3 is purpose-built for businesses seeking to streamline software delivery while maintaining high-quality standards. By leveraging advanced AI, the platform delivers:
- Accelerated Time-to-Market: Generate and maintain test scripts faster with AI-powered automation.
- Enhanced Productivity: Empower non-technical teams to contribute to automation, reducing dependencies on technical resources.
- Comprehensive Test Coverage: Create diverse, realistic test data on demand to ensure your applications perform in real-world scenarios.
- Scalable Solutions: Adapt seamlessly to projects of any size with flexible AI tools tailored to your specific needs.
Key Rapise Features That Redefine Automated Testing
- Natural Language Test Creation: Convert plain-language test scenarios into fully executable scripts to simplify test development. Teams save time and reduce the complexity of scripting, empowering non-technical users to participate in automation.
- AI-Driven Script Maintenance: Automatically update test scripts as applications evolve, reducing the downtime associated with manual updates and ensuring your test suites remain relevant.
- Synthetic Data Generation: Enhance test coverage with realistic, AI-generated test data. Identify edge cases and validate performance across diverse scenarios without relying on manual data preparation.
Built on AWS Bedrock
Rapise v8.3 leverages AWS Bedrock to integrate advanced Anthropic Claude models, including Haiku and Claude 3.5 Sonnet v2. This enables AI Robot and AI Tester features for real-time test reasoning and human-like decision-making. This innovation allows Rapise to perform automated tests dynamically, adapting like a human tester as tests progress.
"Rapise v8.3 is a true game-changer, powered by our partnership with AWS and the incredible technology of AWS Bedrock. By using advanced models like Haiku and Claude 3.5 Sonnet v2, we've created a system that can think and adapt like a human tester, making real-time decisions on the fly. This not only cuts down on manual work and speeds up delivery but also brings teams together, enabling them to collaborate more effectively while achieving incredible accuracy in their testing," said Adam Sandman, CEO of Inflectra.
Seamless Integration for Any Ecosystem
Rapise v8.3 integrates effortlessly with existing development and testing workflows. Whether you're using industry-leading tools like SpiraTest or scaling automation across enterprise environments, Rapise offers the flexibility and customization required for today's complex software ecosystems.
Discover how Rapise v8.3 can revolutionize your testing process. Explore features, tutorials, and more at Inflectra.com.
About Inflectra
Founded in 2006, Inflectra is a global provider of enterprise software solutions designed to help organizations manage projects, requirements, risks, and quality assurance. Known for its award-winning products, including Rapise and Spira, Inflectra specializes in serving highly regulated industries with secure, scalable, and innovative solutions.
Media Contact:
Thea Maisuradze, CMO
Email: 388748@email4pr.com
+1 202-558-6885
View original content:https://www.prnewswire.com/news-releases/rapise-v8-3-ai-powered-test-automation-redefining-quality-assurance-302350042.html
SOURCE Inflectra